Search All
MIN
Search by Name
Search by Ticker
PME
Pro Medicus Ltd
Health Care Technology
·
Healthcare
Turn on notifications
About Pro Medicus Ltd
Commentary
SOURCE
ACTION
FUND MANAGER
DATE
ELM Responsible Investments continues to hold Pro Medicus because the company delivered a significant contract win — a seven-year A$90 million agreement with Beth Israel Lahey Health in Boston — covering Visage Viewer, Workflow and Open Archive. ELM notes the deal is fully cloud-deployable, reinforcing the standardisation of CloudPACS across major healthcare networks. The firm believes the announcement validates the structural growth opportunity in healthcare digitalisation and underscores Pro Medicus' leadership in mission-critical imaging workflow software. ELM highlights the company's strong execution against a deep commercial pipeline and its exceptional competitive advantages in performance, integration and customer trust.
Newsletter
19 Jun 2026
.
ELM Responsible Investments
No Change
Newsletter
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Pro Medicus Ltd (ASX:PME)
Frequently asked questions
Who is investing in Pro Medicus Ltd (ASX:PME)?
Fund managers including Ausbil Investment Management, Oracle Advisory Group, Maple-Brown Abbott, Yarra Capital Management, Ten Cap, ELM Responsible Investments, Kardinia Capital, Antares Capital, First Sentier Investors, Hyperion Asset Management, Lakehouse Capital, Selector Funds Management, Glennon Small Companies, Infinity Asset Management, LHC Capital, Wilson Asset Management, Firetrail Investments, Solaris Investment Management, SG Hiscock & Company, Naos Asset Management, Forager Funds, TMS Capital, Ellerston Capital, Allan Gray, Pendal Group, Tamim Funds Management, Market Partners and Phoenix Growth Fund have invested in Pro Medicus Ltd (ASX:PME).
What is the short interest in Pro Medicus Ltd (ASX:PME)?
The short interest in Pro Medicus Ltd (ASX:PME) is 1.35% which makes it the 184th most shorted stock on the ASX. Of the 104.5M shares that Pro Medicus Ltd has on issue, 1.4M have been sold short.
What does Pro Medicus Ltd (ASX:PME) do?
Pro Medicus Ltd. develops and supplies medical imaging software and Radiology Information Systems (RIS) for hospitals. Founded in 1983 by Sam Aaron Hupert and Anthony Barry Hall, the company is headquartered in Richmond, Australia. Its primary product suite includes the Visage 7 and Visage RIS platforms. Pro Medicus operates globally, with core market segments across Australia, Europe, and North America. The firm specializes in providing advanced health imaging informatics and related services, delivering scalable software solutions designed to support clinical workflow efficiency and enterprise-wide diagnostic imaging requirements for healthcare providers.